FDA Approves Over-the-Counter Sale and Non-Prescription Use of Narcan, a Life-Saving Drug for Opioid Overdoses

The U.S. Food and Drug Administration (FDA) announced on Wednesday that Narcan, a nasal spray that rapidly reverses the effects of an opioid overdose, has been approved for over-the-counter sale and non-prescription use. Narcan is the first naloxone product to be approved for use without a prescription.

Narcan is a drug that can reverse the effects of an overdose, and is now being used across the country, often in cases of heroin use. It requires no special training to administer, and was first approved by the FDA as a prescription drug in 2015.

Don Dahler, a reporter for CBS News, has reported on how the drug is administered, how it works, and its impact in the communities where it is saving lives. He has reported on how the drug is administered, how it works, and its impact in the communities where it is saving lives.

The approval of Narcan for over-the-counter sale and non-prescription use is a major step forward in the fight against opioid overdoses. It is hoped that the availability of the drug will help to reduce the number of overdose deaths in the United States. The FDA is also encouraging healthcare providers to consider prescribing naloxone to patients at risk of an opioid overdose.